DST Raises US$80 Million in Latest Round of Financing

China’s Leading NEV Fleet Management Company Secures One of the Largest US…

Guide Sensmart was present at Big 5 Global 2023, advocating for the digitalization of inspections for building HVAC systems

WUHAN, China, Dec. 11, 2023 /PRNewswire/ — As the largest HVACR exhibition in…

WiMi Developed Holographic Complex Amplitude Computation and Update Technology

BEIJING, Dec. 11, 2023 /PRNewswire/ — WiMi Hologram Cloud Inc. (NASDAQ: WIMI)…

Zhongchao Inc. Collaborates with a Public Health Foundation to Support Sustainable and Effective Cancer Treatments

SHANGHAI, Dec. 11, 2023 /PRNewswire/ — Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or…

"K-Beauty Tech Shines in the U.S." APR Corp. to Showcase Beauty Device Technology at CES 2024

The world’s largest IT-Home Appliance Trade Show, "CES 2024" in Las Vegas,…

Yingli Pharma presents a pivotal Phase 2 study data evaluating linperlisib in relapsed or refractory peripheral T-cell lymphoma in an oral session at the American Society of Hematology 2023 Annual Meeting

Linperlisib achieved Overall Response Rate of 48% with 30% being Complete Response…

Global Times: Renowned French director Luc Besson brings latest work 'Dogman' to China

BEIJING, Dec. 11, 2023 /PRNewswire/ — When Luc Besson’s latest film Dogman hits…